Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α in human bladder tumors and cell lines

Clinical Cancer Research

Volumn 7, Issue 5, 2001, Pages 1263-1272

  Jones, Adam ^a,b,c   Fujiyama, Chisato ^a,c   Blanche, Christine ^a   Moore, John W ^a   Fuggle, Sue ^c   Cranston, David ^b   Bicknell, Roy ^a   Harris, Adrian L ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL HYPOXIA; CELL LINE; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LYMPHOKINES; NUCLEAR PROTEINS; OXYGEN; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034896089     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. What is the evidence that tumors are angiogenesis dependent?
2. The biology of vascular endothelial growth factor
3. Enhancement of tumor growth and vascular density by transfection of vascular endothelial growth factor into MCF-7 breast carcinoma cells
4. Neutralizing anti-vascular endothelial growth factor anti-body completely inhibits angiogenesis and growth of human prostate carcinoma microtumors in vivo
5. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence
6. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer
7. Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates
8. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo
9. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR
10. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
11. Hypoxia response elements in the aldolase A, enolase 1 and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1
12. 2 tension
13. Hypoxia-inducible factor-1α is regulated at the post-mRNA level
14. 2 dependent degradation domain via the ubiquitin-proteasome pathway
15. The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
16. 2 tension
17. Activation of hypoxia-inducible factor-1; definition of regulatory domains within the α subunit
18. HIF-1αis required for solid tumor formation and embryonic vascularization
19. Hypoxia-inducible factor-1 molulates gene expression in solid tumors and influences both angiogenesis and tumor growth
20. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT
21. Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia-inducible factor-1α
22. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development
23. The hypoxia-responsive transcription factor EPAS-1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development
24. Up-regulation of hypoxia-inducible factor-1α is not sufficient for hypoxic/anoxic p53 induction
25. 2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation
26. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix
27. Abrogation of the invasion of human bladder tumor cells by using protease inhibitor(s)
28. Cell-cell adhesion molecules and their associated proteins in bladder cancer cells and their role in mitogen induced cell-cell dissociation and invasion
29. Characterization of a cell line from human transitional cell cancer of the urinary tract
30. Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents
31. Improved RNase protection assay for quantifying LDL-receptor mRNA: Estimation of analytical imprecision and biological variance in peripheral blood mononuclear cells
32. Quantitative measurement of mRNA using the RNase protection assay
33. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-rastransformed cells through a hypoxia inducible factor-1 transcriptional element
34. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: Involvement of HIF-1 in tumor progression
35. Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines
36. High cell density induces vascular endothelial growth factor expression via protein tyrosine phosphorylation
37. Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by cell density
38. The messenger RNA sequences in growing and resting mouse fibroblasts
39. Cell density dependent regulation of basic fibroblast growth factor expression in human renal cell carcinomas
40. Regulation of proliferation-survival decisions during tumor cell hypoxia
41. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts
42. Increased expression of hypoxia inducible factor-1α in rat and human prostate cancer
43. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase
44. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3-kinase/Akt signal transduction pathway
45. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways
46. Loss of PTEN facilitates HIF-1-mediated gene expression
47. Modulation of hypoxia inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics
48. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis
49. Targeting gene expression to hypoxic tumor cells